Alembic receives USFDA approval for clarithromycin tablets
Clarithromycin tablets USP, 250 mg and 500 mg have an estimated market size of US $ 11 million for twelve months ending September 2021 according to IQVIA
Clarithromycin tablets USP, 250 mg and 500 mg have an estimated market size of US $ 11 million for twelve months ending September 2021 according to IQVIA
UCB plans to submit regulatory applications in Q3 2022
It is the first monoclonal antibody drug for use in any animal species
The new plant at Slovenská ?up?a site in Slovakia is scheduled to come on stream in two years
The long-term partnership aims to make fermentation-based biotin available for the full range of relevant applications as a sustainable, non-chemical, European-sourced alternative
Intuitive Telepresence (ITP), facilitates remote learning, and encourages interaction and collaboration between surgeons without the need to travel
The combination enhances Comar's customer value proposition by adding complementary closure and jar products and related precision mold-making expertise
Adbry is the first biologic launched by LEO Pharma in the United States and is expected to be available in pharmacies by February 2022
Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients
Medical footprint expansion with deeper medical grade skin contact material science expertise
Subscribe To Our Newsletter & Stay Updated